ATG101 and hepatocellular carcinoma: In this work, we combined multiple computational methods to create an ATG101-related gene signature to predict prognosis and immune checkpoint blockade (ICB) therapeutic responsiveness in HCC patients, and also discussed the biological implication of this signature.